BrainTrip

BrainTrip is a digital health company developing clinically validated, EEG-based diagnostic tools for early cognitive screening and preventive brain health, designed for practical use in real-world clinical settings. Founded in 2019, the company focuses on translating decades of quantitative EEG research into scalable, clinician-ready solutions that address a long-standing gap between neuroscience research and everyday medical practice. At the core of BrainTrip’s work is the NeuroAI Platform, a modular software suite that enables point-of-care brain assessment by systematically addressing the three main barriers that have limited the clinical adoption of quantitative EEG: data acquisition, signal processing, and clinical interpretation. Through machine-assisted EEG recording, fully automated cloud-based preprocessing, and AI-driven biomarker inference, BrainTrip enables reliable brain assessments without the need for specialized technical staff, complex infrastructure, or disruptive workflow changes.